A Case Series on Placenta Accreta Spectrum Disorder in DMCH, Bihar
- 1. JR, Department of Obstetrics and Gynaecology, Darbhanga Medical College and Hospital (DMCH), Laheriasarai, Bihar
- 2. Senior Resident, Department of Obstetrics and Gynaecology, Darbhanga Medical College and Hospital (DMCH), Laheriasarai, Bihar
- 3. Associate Professor and Head of Department, Department of Obstetrics and Gynaecology, Darbhanga Medical College and Hospital (DMCH), Laheriasarai, Bihar
Description
Following the trend of rising caesarean deliveries, the incidence of placenta accreta spectrum (PAS) is quickly rising globally. The diagnosis and treatment of PAS, a diverse illness with a high prevalence of maternal morbidity and mortality, present special difficulties. The biggest obstacles to gaining a thorough grasp of this syndrome up until now were its rarity, the dearth of high-caliber evidence, and the absence of a standardised method for reporting PAS cases for the ultrasonography, clinical, and pathologic diagnoses. The heterogeneity of the available epidemiological data on PAS has made it difficult to study the available management solutions for this ailment. This review’s objective is to offer a critical assessment of the current body of knowledge regarding PAS diseases’ screening, diagnosis, and treatment choices, with a particular emphasis on the difficulties we anticipate in the near future.
Abstract (English)
Following the trend of rising caesarean deliveries, the incidence of placenta accreta spectrum (PAS) is quickly rising globally. The diagnosis and treatment of PAS, a diverse illness with a high prevalence of maternal morbidity and mortality, present special difficulties. The biggest obstacles to gaining a thorough grasp of this syndrome up until now were its rarity, the dearth of high-caliber evidence, and the absence of a standardised method for reporting PAS cases for the ultrasonography, clinical, and pathologic diagnoses. The heterogeneity of the available epidemiological data on PAS has made it difficult to study the available management solutions for this ailment. This review’s objective is to offer a critical assessment of the current body of knowledge regarding PAS diseases’ screening, diagnosis, and treatment choices, with a particular emphasis on the difficulties we anticipate in the near future.
Files
IJPCR,Vol14,Issue10,Article97.pdf
Files
(362.1 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:1e1c78bd88d699176c342b25db7c5355
|
362.1 kB | Preview Download |
Additional details
Dates
- Accepted
-
2022-10-15
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/14/IJPCR,Vol14,Issue10,Article97.pdf
- Development Status
- Active
References
- 1. Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018; 218(1):75– 87. 2. Chantraine F, Braun T, Gonser M, Henrich W, Tutschek B. Prenatal diagnosis ofabnormally invasive placenta reduces maternal peripartum hemorrhage and morbidity. Acta Obstetricia et Gynecologica Scandinavica. 2013; 92(4): 439–444. 3. Jauniaux E, Chantraine F, Silver RM, Langhoff-Roos J. FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology. Int J Gynecol Obstet. 2018; 140(3):265–273. 4. Morlando M, Sarno L, Napolitano R, et al. Placenta accreta: incidence and risk factors in an area with a particularly high rate of cesarean section. Acta Obstet Gynecol Scand. 2013;92(4):457–460. 5. Fitzpatrick K, Sellers S, Spark P, Kurinczuk J, Brocklehurst P, Knight M. The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. BJOG Int J Obstet Gynaecol. 2014;121(1):62–71. 6. Eller AG, Bennett MA, Sharshiner M, et al. Maternal Morbidity in Cases of Placenta Accreta Managed by a Multidisciplinary Care Team Compared with Standard Obstetric Care. Obstet Gynecol. 2011;117(2, Part 1):331–337. 7. Shamshirsaz AA, Fox KA, Salmanian B, et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol. 2015;212(2): 218.e1-218.e9. 8. E. Jauniaux, D. Ayres-de-Campos, and for the FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel, FIGO consensus guidelines on placenta accreta spectrum disorders: Introduction. International Journal of Gynecology & Obstetrics. 2018;140(3): 261–264.9. J. L. Bailit, W. A. Grobman, M. M. Rice et al., Morbidly adherent placenta treatments and outcomes, Obstetrics and Gynecology. 2015; 125(3):683–689. 10. K. E. Fitzpatrick, S. Sellers, P. Spark, J. J. Kurinczuk, P. Brocklehurst, and M. Knight, The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study, BJOG, 2014; 121(1):62–71. 11. L. Thurn, P. G. Lindqvist, M. Jakobsson et al., Abnormally invasive placenta – prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries, BJOG, 2016; 123(8):1348–1355. 12. F. D'Antonio, C. Iacovella, and A. Bhide, Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis, Ultrasound in Obstetrics & Gynecology, 2013; 42(5):509–517. 13. I. E. Timor-Tritsch, A. Monteagudo, G. Cali et al., Cesarean scar pregnancy and early placenta accreta share common histology, Ultrasound in Obstetrics & Gynecology, 2014; 43(4):383–395. 14. I. E. Timor-Tritsch and A. Monteagudo, Unforeseen consequences of the increasing rate of cesarean deliveries: early placenta accreta and cesarean scar pregnancy. A review, American Journal of Obstetrics and Gynecology, 2012;207(1):14–29. 15. I. E. Timor-Tritsch, F. D'Antonio, G. Calí, J. M. Palacios-Jaraquemada, J. Meyer, and A. Monteagudo, Early firsttrimester transvaginal ultrasound is indicated in pregnancy after previous cesarean delivery: should it be mandatory? Ultrasound in Obstetrics & Gynecology, 2019; 54(2):156–163. 16. J. Panaiotova, M. Tokunaka, K. Krajewska, N. Zosmer, and K. H. Nicolaides, Screening for morbidly adherent placenta in early pregnancy, Ultrasound in Obstetrics & Gynecology, 2019; 53(1):101–106. 17. F. D'Antonio, I. E. Timor-Tritsch, J. Palacios-Jaraquemada et al., Firsttrimester detection of abnormally invasive placenta in high-risk women: systematic review and metaanalysis, Ultrasound in Obstetrics & Gynecology, 2018; 51(2):176–183. 18. R. Granese, E. Gitto, G. D'Angelo et al., Preterm birth: seven-year retrospective study in a single centre population, Italian Journal of Pediatrics, 2019; 45(1):1–6. 19. G. Cali, F. Forlani, I. E. Timor-Tritsch, J. Palacios-Jaraquemada, G. Minneci, and F. D'Antonio, Natural history of cesarean scar pregnancy on prenatal ultrasound: the crossover sign, Ultrasound in Obstetrics & Gynecology, 2017; 50(1):100–104. 20. Y. Wang, G. Tan, X. Cheng, Y. Xu, F. Xu, and P. Qu, Association of hemorrhage at termination in caesarean scar pregnancy using the crossover sign of ultrasound image, Journal of Obstetrics and Gynaecology Research, 2020; 46(8):1378–1383. 21. G. Cali, F. Forlani, L. Giambanco et al., Prophylactic use of intravascular balloon catheters in women with placenta accreta, increta and percreta, European Journal of Obstetrics, Gynecology and Reproductive Biology, 2014; 179: 36– 41.